The Heart Failure Drugs Market segment analysis categorizes the market into ACE inhibitors, beta-blockers, ARNI, SGLT2 inhibitors, and other supportive medications. ACE inhibitors and beta-blockers remain dominant due to longstanding clinical efficacy, while newer drug classes like ARNI and SGLT2 inhibitors are gaining rapid adoption. Segment analysis shows how each therapeutic class addresses...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt